PATLY.AI
Patent AnalyticsExaminers
Menu
ExaminersSearch
Rankings
InventorsThe most prolific and the fastest-rising inventorsPlacesCities and countries with the most patentsCompaniesEvery company and institution that filesLaw firmsEvery firm and agent that prosecutesExaminer leaderboardsExaminers ranked on every measure
More
TrendsOfficeCompare

Application

17769966 · INTRANASAL PHARMACEUTICAL COMPOSITIONS OF CGRP INHIBITORS

Save

Filed 2022-04-18 · Abandoned The official file ↗ · Art unit 1623 · Examiner Yong Soo Chong Typical · CPC A61K 9/0043 · Pfizer Ireland Pharmaceuticals · Pfizer Inc.

Office actions
0
first was Restriction requirement
RCEs
0
no appeal
To first action
34.5 mo
to disposition 41.9 mo
Statutes raised
·
0 actions read
Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in